In most of the studies, circulating HBV-specific CD8+ T-cell levels were similar between CHB patients and patients with HBV-associated HCC [21,32,41,59,61], whereas one study showed lower levels in HBV-associated HCC [50]. Here, CD8A is linked to hepatocellular carcinoma.